|
|
News Breaks | | | | February 12, 2013 | | 06:02 EDT |  | AMRN | Amarin announces notification of patent allowance for patent related to Vescepa
Amarin announced that the United States Patent and Trademark Office has published notification of Notice of Allowance for U.S. Patent Application Serial Number 13/614,129. This application includes claims intended to protect the Vascepa indication approved by the FDA based on Amarin's MARINE clinical trial results. The claims in this allowed application cover a method of use relating to Vascepa's MARINE indication. Specifically, the allowed independent claim covers use of a pharmaceutical composition comprising 2000 mg to about 5000 mg of icosapent ethyl, or EPA, independent of DHA content, present in one or more capsules, to reduce triglycerides by at least 20%. | |
|
News For AMRN From The Last 14 Days Check below for free stories on AMRN the last two weeks. |
|
|
| June 19, 2013 | | 08:04 EDT | | AMRN | Amarin informed by FDA of Oct. 16 advisory committee date for sNDA for Vascepa
 Subscribe for More Information | | | June 11, 2013 | | 05:56 EDT |  | AMRN | Stocks with implied volatility movement; AMRN SODA
Stocks with implied volatility movement; Amarin (AMRN), SodaStream (SODA) according to IVolatility. | |
|
|
|
|
|
|
